Fortress Biotech, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $84.7M | $26.2M | $136.9M |
| FY2020 | $51.7M | $100.3M | $233.4M |
| FY2021 | $42.9M | $108.7M | $305.7M |
| FY2022 | $91.7M | $41.7M | $178.3M |
| FY2023 | $60.9M | $22.5M | $80.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $84.7M | $26.2M | $136.9M |
| FY2020 | $51.7M | $100.3M | $233.4M |
| FY2021 | $42.9M | $108.7M | $305.7M |
| FY2022 | $91.7M | $41.7M | $178.3M |
| FY2023 | $60.9M | $22.5M | $80.9M |